drugset / Trial / NCT02373371

Actinic Keratoses Treatment With Metvix® in Combination With Light

NCT02373371

RandomizedSingle-groupOpen-labelTreatment

Summary

The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy in subjects with mild actinic keratoses (intra-individual comparison)

Timeline

Start
2015-03-25
Primary completion
2016-11-22
Completion
2018-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject methyl aminolevulinate Small molecule 160 unknown Topical

Indications